Virtu Financial’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,490
Closed -$21K 1818
2023
Q2
$21K Buy
2,490
+989
+66% +$8.34K ﹤0.01% 1254
2023
Q1
$7K Buy
+1,501
New +$7K ﹤0.01% 1377
2022
Q1
Sell
-1,538
Closed -$120K 1964
2021
Q4
$120K Buy
+1,538
New +$120K 0.01% 1054